Published in Nutrients on January 20, 2015
Effect of a cheese rich in angiotensin-converting enzyme-inhibiting peptides (Gamalost(®)) and a Gouda-type cheese on blood pressure: results of a randomised trial. Food Nutr Res (2016) 0.75
Whey protein lowers blood pressure and improves endothelial function and lipid biomarkers in adults with prehypertension and mild hypertension: results from the chronic Whey2Go randomized controlled trial. Am J Clin Nutr (2016) 0.75
Secretome of Intestinal Bacilli: A Natural Guard against Pathologies. Front Microbiol (2017) 0.75
Bioactive Peptides. Foods (2017) 0.75
2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens (2003) 12.49
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med (2009) 12.16
How should meta-regression analyses be undertaken and interpreted? Stat Med (2002) 8.96
Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ (2011) 6.80
Dietary approaches to prevent and treat hypertension: a scientific statement from the American Heart Association. Hypertension (2006) 5.59
Variance imputation for overviews of clinical trials with continuous response. J Clin Epidemiol (1992) 4.72
Individual patient- versus group-level data meta-regressions for the investigation of treatment effect modifiers: ecological bias rears its ugly head. Stat Med (2002) 2.49
Randomized controlled trial of sour milk on blood pressure in borderline hypertensive men. Am J Hypertens (2004) 1.77
A randomized, double-blind, placebo-controlled trial of casein protein hydrolysate (C12 peptide) in human essential hypertension. Am J Hypertens (2004) 1.60
Acute effects of whey protein isolate on blood pressure, vascular function and inflammatory markers in overweight postmenopausal women. Br J Nutr (2011) 1.46
A fermented milk high in bioactive peptides has a blood pressure-lowering effect in hypertensive subjects. Am J Clin Nutr (2003) 1.45
Ethnic differences in cardiovascular drug response: potential contribution of pharmacogenetics. Circulation (2008) 1.44
A placebo-controlled study of the effect of sour milk on blood pressure in hypertensive subjects. Am J Clin Nutr (1996) 1.30
Lactobacillus helveticus fermented milk lowers blood pressure in hypertensive subjects in 24-h ambulatory blood pressure measurement. Am J Hypertens (2005) 1.17
Epidemiologic findings on body mass and blood pressure in adults. Ann Epidemiol (1991) 1.16
Mechanisms and clinical implications of blood pressure variability. J Cardiovasc Pharmacol (2000) 1.11
Effect of powdered fermented milk with Lactobacillus helveticus on subjects with high-normal blood pressure or mild hypertension. J Am Coll Nutr (2005) 1.08
Effect of milk tripeptides on blood pressure: a meta-analysis of randomized controlled trials. Nutrition (2008) 1.03
The chronic effects of whey proteins on blood pressure, vascular function, and inflammatory markers in overweight individuals. Obesity (Silver Spring) (2009) 1.01
Updated meta-analytical approach to the efficacy of antihypertensive drugs in reducing blood pressure. Clin Drug Investig (2007) 0.98
Long-term intervention with Lactobacillus helveticus fermented milk reduces augmentation index in hypertensive subjects. Eur J Clin Nutr (2010) 0.98
Effect of a milk drink supplemented with whey peptides on blood pressure in patients with mild hypertension. Eur J Nutr (2006) 0.96
Retracted Effects of whey peptides on cardiovascular disease risk factors. J Clin Hypertens (Greenwich) (2006) 0.95
Effect of administration of fermented milk containing whey protein concentrate to rats and healthy men on serum lipids and blood pressure. J Dairy Sci (2000) 0.95
Effect of ingesting sour milk fermented using Lactobacillus helveticus bacteria producing tripeptides on blood pressure in subjects with mild hypertension. J Hum Hypertens (2004) 0.94
Blood pressure lowering effect of lactotripeptides assumed as functional foods: a meta-analysis of current available clinical trials. J Hum Hypertens (2010) 0.92
Lactotripeptides show no effect on human blood pressure: results from a double-blind randomized controlled trial. Hypertension (2007) 0.91
Effect of casein hydrolysate, prepared with protease derived from Aspergillus oryzae, on subjects with high-normal blood pressure or mild hypertension. J Med Food (2005) 0.91
Enzymatically hydrolyzed lactotripeptides do not lower blood pressure in mildly hypertensive subjects. Am J Clin Nutr (2008) 0.89
Human in vivo study of the renin-angiotensin-aldosterone system and the sympathetic activity after 8 weeks daily intake of fermented milk. Clin Physiol Funct Imaging (2010) 0.87
Additive beneficial effects of lactotripeptides intake with regular exercise on endothelium-dependent dilatation in postmenopausal women. Am J Hypertens (2010) 0.87
A spread containing bioactive milk peptides Ile-Pro-Pro and Val-Pro-Pro, and plant sterols has antihypertensive and cholesterol-lowering effects. Food Funct (2012) 0.87
The antihypertensive effect of fermented milk in individuals with prehypertension or borderline hypertension. J Hum Hypertens (2010) 0.86
Additive beneficial effects of lactotripeptides and aerobic exercise on arterial compliance in postmenopausal women. Am J Physiol Heart Circ Physiol (2009) 0.85
Do the lactotripeptides isoleucine-proline-proline and valine-proline-proline reduce systolic blood pressure in European subjects? A meta-analysis of randomized controlled trials. Am J Hypertens (2013) 0.85
Antihypertensive effect of casein hydrolysate in a placebo-controlled study in subjects with high-normal blood pressure and mild hypertension. Br J Nutr (2005) 0.85
Acute ingestion of a novel whey-derived peptide improves vascular endothelial responses in healthy individuals: a randomized, placebo controlled trial. Nutr J (2009) 0.84
Dose-dependent lowering of blood pressure by dairy peptides in mildly hypertensive subjects. Blood Press (2009) 0.83
Casein hydrolysate containing Val-Pro-Pro and Ile-Pro-Pro improves central blood pressure and arterial stiffness in hypertensive subjects: a randomized, double-blind, placebo-controlled trial. Atherosclerosis (2011) 0.83
Effect of an excess intake of casein hydrolysate containing Val-Pro-Pro and Ile-Pro-Pro in subjects with normal blood pressure, high-normal blood pressure, or mild hypertension. Biosci Biotechnol Biochem (2011) 0.82
Fermented lactotripeptides-containing milk lowers daytime blood pressure in high normal-to-mild hypertensive subjects. J Hum Hypertens (2008) 0.82
IPP-rich milk protein hydrolysate lowers blood pressure in subjects with stage 1 hypertension, a randomized controlled trial. Nutr J (2010) 0.82
Lactotripeptides do not lower ambulatory blood pressure in untreated whites: results from 2 controlled multicenter crossover studies. Am J Clin Nutr (2008) 0.82
Bovine casein hydrolysate (c12 Peptide) reduces blood pressure in prehypertensive subjects. Am J Hypertens (2007) 0.82
Lactotripeptides intake and blood pressure management: a meta-analysis of randomised controlled clinical trials. Nutr Metab Cardiovasc Dis (2013) 0.81
Ile-Pro-Pro and Val-Pro-Pro tripeptide-containing milk product has acute blood pressure lowering effects in mildly hypertensive subjects. Clin Exp Hypertens (2011) 0.80
Antihypertensive effects of bioactive tripeptides-a random effects meta-analysis. Ann Med (2012) 0.80
Beneficial potential of casein hydrolysate containing Val-Pro-Pro and Ile-Pro-Pro on central blood pressure and hemodynamic index: a preliminary study. J Med Food (2009) 0.79
The impact of lactotripeptides on blood pressure response in stage 1 and stage 2 hypertensives. J Clin Hypertens (Greenwich) (2010) 0.79
The blood pressure lowering effect of lactotripeptides and salt intake in 24-h ambulatory blood pressure measurements. Clin Exp Hypertens (2010) 0.79
Hemodynamic effects of lactotripeptides from casein hydrolysate in Mediterranean normotensive subjects and patients with high-normal blood pressure: a randomized, double-blind, crossover clinical trial. J Med Food (2010) 0.78
Does the cis/trans configuration of peptide bonds in bioactive tripeptides play a role in ACE-1 enzyme inhibition? Biologics (2014) 0.77
Effects of long-term intake of lactotripeptides on cardiovascular risk factors in hypertensive subjects. Eur J Clin Nutr (2012) 0.77
Predictors of the short-term effect of isoleucine-proline-proline/valine-proline-proline lactotripeptides from casein on office and ambulatory blood pressure in subjects with pharmacologically untreated high-normal blood pressure or first-degree hypertension. Clin Exp Hypertens (2012) 0.76
Effects of Val-Pro-Pro and Ile-Pro-Pro on nondipper patients: a preliminary study. J Med Food (2011) 0.76
Apples and cardiovascular health--is the gut microbiota a core consideration? Nutrients (2015) 0.80